Proteomics International Laboratories Limited (PIQ.AX)
AUD 0.64
(-2.31%)
AUD 0.64
(-2.31%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 | 316.39 Thousand AUD | 393.69% |
| 2023 | 64.08 Thousand AUD | 0.0% |
| 2022 | - AUD | -100.0% |
| 2021 | 69.04 Thousand AUD | -48.02% |
| 2020 | 132.84 Thousand AUD | -19.45% |
| 2019 | 164.92 Thousand AUD | -47.21% |
| 2018 | 312.42 Thousand AUD | -64.31% |
| 2017 | 875.39 Thousand AUD | 98.1% |
| 2016 | 441.89 Thousand AUD | 0.0% |
| 2015 | 441.89 Thousand AUD | 2839.08% |
| 2014 | 15.03 Thousand AUD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q4 | 316.39 Thousand AUD | 0.0% |
| 2024 Q2 | 46.38 Thousand AUD | 0.0% |
| 2024 FY | 316.39 Thousand AUD | 393.69% |
| 2023 Q4 | 64.08 Thousand AUD | 0.0% |
| 2023 FY | 64.08 Thousand AUD | 0.0% |
| 2023 Q3 | - AUD | 0.0% |
| 2023 Q1 | - AUD | 0.0% |
| 2023 Q2 | - AUD | 0.0% |
| 2022 Q2 | 35.04 Thousand AUD | 0.0% |
| 2022 Q4 | - AUD | 0.0% |
| 2022 FY | - AUD | -100.0% |
| 2022 Q3 | - AUD | -100.0% |
| 2021 Q4 | 69.04 Thousand AUD | 0.0% |
| 2021 Q3 | - AUD | -100.0% |
| 2021 FY | 69.04 Thousand AUD | -48.02% |
| 2021 Q1 | - AUD | -100.0% |
| 2021 Q2 | 101.42 Thousand AUD | 0.0% |
| 2020 Q4 | 132.84 Thousand AUD | 0.0% |
| 2020 FY | 132.84 Thousand AUD | -19.45% |
| 2020 Q3 | - AUD | -100.0% |
| 2020 Q2 | 162.72 Thousand AUD | 0.0% |
| 2019 Q3 | - AUD | -100.0% |
| 2019 Q4 | 164.92 Thousand AUD | 0.0% |
| 2019 FY | 164.92 Thousand AUD | -47.21% |
| 2019 Q1 | - AUD | -100.0% |
| 2019 Q2 | 84.77 Thousand AUD | 0.0% |
| 2018 Q1 | - AUD | -100.0% |
| 2018 Q4 | 312.42 Thousand AUD | 0.0% |
| 2018 FY | 312.42 Thousand AUD | -64.31% |
| 2018 Q2 | 607.1 Thousand AUD | 0.0% |
| 2018 Q3 | - AUD | -100.0% |
| 2017 Q1 | - AUD | -100.0% |
| 2017 FY | 875.39 Thousand AUD | 98.1% |
| 2017 Q4 | 875.39 Thousand AUD | 0.0% |
| 2017 Q2 | 441.89 Thousand AUD | 0.0% |
| 2017 Q3 | - AUD | -100.0% |
| 2016 Q3 | - AUD | -100.0% |
| 2016 Q1 | - AUD | -100.0% |
| 2016 FY | 441.89 Thousand AUD | 0.0% |
| 2016 Q4 | 441.89 Thousand AUD | 0.0% |
| 2016 Q2 | 441.89 Thousand AUD | 0.0% |
| 2015 Q1 | - AUD | 0.0% |
| 2015 Q4 | 441.89 Thousand AUD | 0.0% |
| 2015 FY | 441.89 Thousand AUD | 2839.08% |
| 2015 Q3 | - AUD | 0.0% |
| 2014 FY | 15.03 Thousand AUD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | 123.85 Thousand AUD | -155.454% |
| Anatara Lifesciences Ltd | - AUD | -Infinity% |
| Zelira Therapeutics Limited | 5.65 Million AUD | 94.404% |
| Biome Australia Limited | 1.3 Million AUD | 75.769% |
| Patrys Limited | - AUD | -Infinity% |
| Orthocell Limited | 689.69 Thousand AUD | 54.125% |
| Imugene Limited | 1.54 Million AUD | 79.547% |
| Noxopharm Limited | - AUD | -Infinity% |
| PYC Therapeutics Limited | 1.11 Million AUD | 71.567% |
| Chimeric Therapeutics Limited | - AUD | -Infinity% |
| Prescient Therapeutics Limited | 330.48 Thousand AUD | 4.264% |
| Cynata Therapeutics Limited | - AUD | -Infinity% |
| CSL Limited | 18.24 Billion AUD | 99.998% |
| Arovella Therapeutics Limited | - AUD | -Infinity% |
| Bio-Gene Technology Limited | - AUD | -Infinity% |
| Clinuvel Pharmaceuticals Limited | 879.78 Thousand AUD | 64.037% |
| Starpharma Holdings Limited | 3.52 Million AUD | 91.032% |
| Nanollose Limited | 42.53 Thousand AUD | -643.934% |
| Memphasys Limited | 4.41 Million AUD | 92.831% |
| Invex Therapeutics Ltd | - AUD | -Infinity% |
| NeuroScientific Biopharmaceuticals Limited | - AUD | -Infinity% |
| Amplia Therapeutics Limited | 1.56 Million AUD | 79.741% |
| Botanix Pharmaceuticals Limited | - AUD | -Infinity% |
| Island Pharmaceuticals Limited | 421.96 Thousand AUD | 25.019% |
| Race Oncology Limited | - AUD | -Infinity% |
| Nyrada Inc. | - AUD | -Infinity% |
| Telix Pharmaceuticals Limited | 17.44 Million AUD | 98.186% |
| Dimerix Limited | 149.68 Thousand AUD | -111.377% |
| PharmAust Limited | - AUD | -Infinity% |
| Immutep Limited | 1.22 Million AUD | 74.241% |
| Clarity Pharmaceuticals Ltd | - AUD | -Infinity% |
| Alterity Therapeutics Limited | 159.04 Thousand AUD | -98.934% |
| BTC Health Limited | - AUD | -Infinity% |
| Acrux Limited | 1.48 Million AUD | 78.723% |
| Neuren Pharmaceuticals Limited | - AUD | -Infinity% |
| Biotron Limited | 7130.00 AUD | -4337.518% |
| Tissue Repair Ltd | - AUD | -Infinity% |
| AdAlta Limited | 2.49 Million AUD | 87.317% |
| Radiopharm Theranostics Limited | - AUD | -Infinity% |
| Hexima Limited | - AUD | -Infinity% |
| AnteoTech Limited | 23.59 Thousand AUD | -1241.111% |
| Paradigm Biopharmaceuticals Limited | 239.33 Thousand AUD | -32.2% |
| Recce Pharmaceuticals Ltd | 811.19 Thousand AUD | 60.996% |
| Avecho Biotechnology Limited | 175.15 Thousand AUD | -80.641% |
| Actinogen Medical Limited | 319.06 Thousand AUD | 0.838% |
| Immuron Limited | 173.49 Thousand AUD | -82.363% |
| Argenica Therapeutics Limited | - AUD | -Infinity% |